Research

SACHA: Accelerate children’s access to innovative molecules – Interview with Dr. Pablo Berlanga

SACHA: Accelerate children’s access to innovative molecules – Interview with Dr. Pablo Berlanga

SACHA: Accelerate children’s access to innovative molecules – Interview with Dr. Pablo Berlanga

France is a pioneer in Europe in the development of new drugs in pediatric oncology. For example, within the ITCC network (Innovative Therapies for Children and adolescents with Cancer, 14 countries), France accounts for 50% of inclusions in early clinical trials. Since 2014, specific measures have been put in place in France as part of […]

BIOMEDE: HOPE FOR Diffuse Intrinsic pontine glioma

BIOMEDE: HOPE FOR Diffuse Intrinsic pontine glioma

BIOMEDE: HOPE FOR Diffuse Intrinsic pontine glioma

BIOMEDE is the most ambitious clinical trial ever proposed for children with a Diffuse Intrinsic pontine glioma. This malignant brain tumor is highly aggressive and is located in a vital area of the brainstem called the pons. This cerebral region controls vital functions such as balance, breathing, heart rate, blood pressure, and is also traversed […]

BIOMEDE: A Therapeutic Revolution for Diffuse Intrinsec Pontine Glioma (DIPG)

BIOMEDE: A Therapeutic Revolution for Diffuse Intrinsec Pontine Glioma (DIPG)

BIOMEDE: A Therapeutic Revolution for Diffuse Intrinsec Pontine Glioma (DIPG)

BIOMEDE is the most ambitious clinical trial offered to children suffering from DIPG. This malignant brain tumor is highly aggressive and is located in a vital area of the brainstem called the pons. This cerebral region controls essential functions such as balance, breathing, heart rate and blood pressure. It is also traversed by nerves that […]

IMAGINE FOR MARGO X INSTITUT CURIE: 10 YEARS OF SHARED HISTORY AGAINST CHILDREN’S CANCER

IMAGINE FOR MARGO X   INSTITUT CURIE: 10 YEARS OF SHARED HISTORY AGAINST CHILDREN’S CANCER

IMAGINE FOR MARGO X INSTITUT CURIE: 10 YEARS OF SHARED HISTORY AGAINST CHILDREN’S CANCER

This Thursday, September 14, 2023, we organized with the Institut Curie an evening dedicated to the 10 years of our collaboration. Researchers, pediatricians, donors and volunteers came together to celebrate 10 years of innovations for the benefit of children and adolescents with cancer. Among the 42 research programs that we have funded since 2011, 12 […]

FIGHT KIDS CANCER 2023: 9 EUROPEAN RESEARCH PROGRAMS SELECTED

FIGHT KIDS CANCER 2023: 9 EUROPEAN RESEARCH PROGRAMS SELECTED

FIGHT KIDS CANCER 2023: 9 EUROPEAN RESEARCH PROGRAMS SELECTED

Fight Kids Cancer is a European call for projects that we launched in 2020 with the Belgian KickCancer Foundation and the Luxembourg Kriibskrank Kanner Foundation in collaboration with the ESF – European Science Foundation – and a committee of international scientific experts. Today, Fight Kids Cancer has 6 member countries. Indeed, Cris (Spain) and KiKa […]

WHAT IS A BRAIN TUMOR IN CHILDREN?

WHAT IS A BRAIN TUMOR IN CHILDREN?

WHAT IS A BRAIN TUMOR IN CHILDREN?

Childhood brain tumors are abnormal growths of cells in the brain or central nervous system. They represent the second form of cancer in children after leukemia. Central nervous system tumors are the most frequent solid tumors in children (30% of tumors) and affect more than 3,000 children per year in Europe and approximately 500 per […]

WHAT IS RETINOBLASTOMA?

WHAT IS RETINOBLASTOMA?

WHAT IS RETINOBLASTOMA?

Retinoblastoma is a malignant tumor that grows in the retina, the layer of light-sensitive tissue at the back of the eye. This tumor forms from immature cells in the retina called “developing retinal cells”. Retinoblastoma is a cancer that mainly affects young children, usually before the age of 5 (5% of cases are diagnosed in […]

HOW TO TREAT PEDIATRIC CANCERS?

HOW TO TREAT PEDIATRIC CANCERS?

HOW TO TREAT PEDIATRIC CANCERS?

The management of cancer in children is based on two axes: on the one hand conventional treatments and on the other hand innovative treatments based on precision medicine. Imagine for Margo has been mobilizing for more than 10 years to improve access to this care at the cutting edge of scientific progress. PEDIATRIC CANCER IN […]